Glenmark Pharma.

GLENMARK27 Feb 2024
Pharmaceuticals
-1.00 (-0.11%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glenmark Pharma.
Glenmark Pharma.
Pharmaceuticals
GLENMARK27 Feb 2024
-1.00 (-0.11%)
1D
1M
6M
1Y
5Y
All

Glenmark Pharma. - Share Price & Details

Lowest Today
918
Highest Today
936
Today’s Open
931.8
Prev. Close
927.45
52 Week High
941.65
52 Week Low
414.5
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
114.32%
Upper Circuit
Lower Circuit
P/E TTM
24.87
P/B Ratio
1.42
Traded Value(Cr)
0.00
EPS TTM
37.29
Book value
Dividend
0.27%

Price Performance

7.53 %
1 Wk
3.03 %
1 M
20.28 %
3 M
114.32 %
1 Y
8.38 %
YTD

Traded Volume Movement

Technical Details

Support 3
899
Support 2
909
Support 1
918
Pivot Point :
928
Resistance 1
937
Resistance 2
947
Resistance 3
957

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glenmark Pharmaceuticals Ltd
₹926.45(-1.00/-0.11%)
926.45-1.0026,169.69114.3224.871.42
Bliss GVS Pharma Ltd
₹137.60(+7.65/5.89%)
137.60+7.651,360.4667.5719.931.39
Astrazeneca Pharma India Ltd
₹5,494.25(+32.90/0.60%)
5,494.25+32.9013,653.3864.3585.6020.85
Cipla Ltd
₹1,478.35(+8.60/0.59%)
1,478.35+8.60118,661.6754.6536.094.58
Abbott India Ltd
₹28,732.05(+248.60/0.87%)
28,732.05+248.6060,527.3338.2052.8419.47
Amrutanjan Health Care Ltd
₹656.75(+1.45/0.22%)
656.75+1.451,915.489.8343.517.31

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 26169.69 crores. It has reported a sales of Rs. 1304.16 crores and a net profit of Rs. -20.41 crores for the quarter ended December 2018. The company management includes Glenn Saldanha, Glenn Saldanha,Cheryl Pinto,V S Mani,B E Saldanha,Rajesh Desai.,Devendra Raj Mehta,Bernard Munos,Brian W Tempest,Sridhar Gorthi,Sona Saira Ramasastry,Dipankar Bhattacharjee,V R Iyer (Glenmark Pharmaceuticals Ltd) among others.
Chairman
Glenn Saldanha
Registered office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai,Maharashtra,400026
FAX :91-22-40189986
Background
Incorporation Year1977
Face Value₹1
Market Lot1

Latest News

Buy or sell: Vaishali Parekh recommends three stocks to buy today!
Buy or sell stocks for the Indian stock market today: Following weak global market sentiments, the Indian stock market ended lower on Monday. The Nifty 50 index lost 90 points and closed at the 22,122 level, the BSE Sensex dipped 352 points and ended at the 72,790 mark whereas the Bank Nifty index corrected 235 points and closed at the 46,576 level.
27 Feb 2024 | 12:39 PM
📢 Benchmark indices open on a flat note today; Nifty near 22,000
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex lost 77.47 points or 0.11% at 72,712.66 and the Nifty was down 23.90 points or 0.11% at 22,098.
📢Havells India (⬆️2.14%), HDFC AMC (⬆️2.06%) and ICICI Lombard (⬆️2.01%) appeared as the top performers on the Nifty50 at open.
27 Feb 2024 | 09:29 AM
Nifty signals subdued sessions ahead: Key technical indicators!
The Nifty benchmark index began the week with a slight downturn, slipping to an intraday low of 22,075 during the first hour on February 26. There was some recovery thereon, but the index eventually closed 0.41 percent lower at 22,122. Analysts caution traders against building aggressive long positions on Nifty 50, since technical indicators are showing overbought conditions in the index.
27 Feb 2024 | 09:09 AM
Before Market Opens: 9 essential things to know at 9 am on February 27
Before Market Opens: Indian markets are likely to open lower on Tuesday following caution global peers with Asian shares on the back of slightly warmer-than-expected Japanese inflation, while the US stock market ended lower on Monday. Gift Nifty was trading 59 points lower, indicating a weak start for benchmark Nifty. Let's take a look at some key cues before the market opens today!!
27 Feb 2024 | 09:01 AM
Nifty 50, Sensex today: What to expect from Indian stock market in trade
The Indian stock market indices, Sensex and Nifty 50, are expected to open on a muted note Tuesday tracking mixed global market cues.The trends on Gift Nifty also indicate a tepid start for the Indian benchmark index. The Gift Nifty was trading around 22,134 level as compared to the Nifty futures’ previous close of 22,138.On Monday, the domestic equity indices ended lower.
27 Feb 2024 | 08:20 AM

How has the GLENMARK share price performed in the past year?

In April 2022, the huge pharmaceutical GLENMARK’s share price was in the region of Rs. 478. By June, it had dipped to the late 300 levels and never significantly went up till November. Highs were felt in December, and February 2023, and now the stock is at the 448 level.

Does GLENMARK pay dividends to its shareholders?

GLENMARK has a consistent track record of paying dividends to its loyal shareholders. In the recent past, the company has paid only final dividends, but interim dividends have been paid in the past as well.

What is the dividend yield of GLENMARK?

The dividend yield of GLENMARK is 0.56% (March 2022).

How does GLENMARK compare to its competitors in terms of share price?

Compared to popular competitors of GLENMARK, like Sun Pharma, Dr Reddy’s Labs, CIPLA, Torrent Pharma, Abbott India and others, the company’s share price is low at the moment (March 2023). Most of these companies have their share prices in the thousands, or late hundreds, whereas GLENMARK seems firmly poised on the mid-hundred mark.

What is the company's debt-to-equity ratio?

The company’s debt-to-equity ratio is 0.22.

What is the company's revenue and net income?

The revenue of GLENMARK is Rs. 3,463 crores (Q3 FY 2022-23)  and the net income is Rs. 291 crores (December 2022).

How long has GLENMARK been in business?

GLENMARK started its foray into the pharmaceutical business with “Candid Cream”, a key dermatological drug, even in use now. The company started its business in 1977, headed by its Founder Emeritus, the late Gracias Saldanha.

What is the company's history of share price performance?

The share price of GLENMARK has been somewhat stable in the last 4-5 years, not showing much volatility as other pharma stocks have. In 2018, the share was in the region of the 500 mark, peaking at nearly 700 in 2019. Then, with a gradual and slow downward movement, it dipped to the region of 199 in 2020, only to slowly rise to 662 in 2021. Since then, it has been in the range of between 400-500 and is steady now.
Click here to see your activities